SFRP1 and neoplasm: Another potential tumor suppressor upregulated in topotecan-resistant patients is SFRP1, a member of the secreted frizzled-related protein (SFRP) gene family that shares sequence homology with Fzd receptors, can sequester Wnt ligands and antagonize Wnt signaling [54].